药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
3-Methylfentanyl
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Tetrandrine.
3-Methylfentanyl
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Tetrandrine.
3-Methylfentanyl
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Roflumilast
Roflumilast may increase the immunosuppressive activities of Tetrandrine.
3-Methylfentanyl
Difluocortolone
The risk or severity of adverse effects can be increased when Difluocortolone is combined with Tetrandrine.
3-Methylfentanyl
Clobetasol
The risk or severity of adverse effects can be increased when Clobetasol is combined with Tetrandrine.
3-Methylfentanyl
Fluocortolone
The risk or severity of adverse effects can be increased when Fluocortolone is combined with Tetrandrine.
3-Methylfentanyl
Hydrocortisone butyrate
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Hydrocortisone butyrate.
3-Methylfentanyl
Emapalumab
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Emapalumab.
3-Methylfentanyl
Siponimod
The risk or severity of adverse effects can be increased when Siponimod is combined with Tetrandrine.
3-Methylfentanyl
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Tetrandrine.
3-Methylfentanyl
Siltuximab
The risk or severity of adverse effects can be increased when Siltuximab is combined with Tetrandrine.
3-Methylfentanyl
Secukinumab
The risk or severity of adverse effects can be increased when Secukinumab is combined with Tetrandrine.
3-Methylfentanyl
Certolizumab pegol
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Tetrandrine.
3-Methylfentanyl
Golimumab
The risk or severity of adverse effects can be increased when Golimumab is combined with Tetrandrine.
3-Methylfentanyl
Rilonacept
The risk or severity of adverse effects can be increased when Rilonacept is combined with Tetrandrine.
3-Methylfentanyl
Tocilizumab
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Tetrandrine.
3-Methylfentanyl
Canakinumab
The risk or severity of adverse effects can be increased when Canakinumab is combined with Tetrandrine.
3-Methylfentanyl
Afelimomab
The risk or severity of adverse effects can be increased when Afelimomab is combined with Tetrandrine.
3-Methylfentanyl
Bleselumab
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Bleselumab.